FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease

1. Garcia-Gomara, M.
2. Legarra-Marcos, N.
3. Serena, M.
4. Rojas-de-Miguel, E.
5. Espelosin, M.
6. Marcilla, I.
7. Perez-Mediavilla, A.
8. Luquin, M.R.
9. Lanciego, J.L.
10. Burrell, M.A.
11. Cuadrado-Tejedor, M.
12. Garcia-Osta, A.